glp 1 gastrointestinal side effects Why Semaglutide Causes Diarrhea: Understanding GLP-1 on Gut Motility & Digestion Overdose risks increase as demand
Description
Beyond weight loss, the SELECT trial showed semaglutide reduces major adverse cardiovascular events by 20 percent in patients with obesity and established cardiovascular disease, even without diabetes [Lincoff SELECT, NEJM 2023]
What Is Driving Demand in Germany
Our tester noted that this is a larger serving size, requiring three medium-sized capsules per dose
The perks being offered included free nurses and reimbursement support services to push providers to prescribe this lucrative injection to patients
It is similar enough to GLP-1 to allow it to fit into the GLP-1 receptor and act as an agonist
Our guide on peptides versus TRT explores the differences between these approaches
